Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.36B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$236M |
| 3 |
Apple
AAPL
|
+$223M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$222M |
| 5 |
Southern Company
SO
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FON
SPRINT CORP FON COM
FON
|
+$724M |
| 2 |
Pfizer
PFE
|
+$469M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$409M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$407M |
| 5 |
Zoetis
ZTS
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.63% |
| 2 | Healthcare | 4.25% |
| 3 | Technology | 4.18% |
| 4 | Energy | 3.42% |
| 5 | Communication Services | 3.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Murphy USA
MUSA
$10.1B
| $1.94M | ﹤0.01% |
+48,626
| New | +$1.95M |
|
|
CMCSK
2577
CALL
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $1.94M | ﹤0.01% |
45,200
+7,600
| +20% | +$327K |
|
2578
Synaptics
SYNA
$4.21B
| $1.94M | ﹤0.01% |
44,154
-20,977
| -32% | -$858K |
|
2579
CALL
Canadian Natural Resources
CNQ
$97.3B
| $1.94M | ﹤0.01% |
129,284
+47,370
| +58% | +$711K |
|
2580
iShares Russell Mid-Cap ETF
IWR
$57.7B
| $1.94M | ﹤0.01% |
55,776
+5,584
| +11% | +$191K |
|
2581
LCI Industries
LCII
$2.6B
| $1.94M | ﹤0.01% |
43,060
-5,289
| -11% | -$224K |
|
2582
PUT
Canadian Imperial Bank of Commerce
CM
$109B
| $1.94M | ﹤0.01% |
50,017
+8,574
| +21% | +$320K |
|
|
WGL
2583
DELISTED
Wgl Holdings
WGL
| $1.94M | ﹤0.01% |
46,073
+6,609
| +17% | +$287K |
|
|
AAN.A
2584
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $1.94M | ﹤0.01% |
71,667
+8,678
| +14% | +$234K |
|
|
JAH
2585
DELISTED
JARDEN CORPORATION
JAH
| $1.93M | ﹤0.01% |
60,414
-25,820
| -30% | -$797K |
|
2586
CALL
AstraZeneca
AZN
$249B
| $1.93M | ﹤0.01% |
37,900
-200
| -0.5% | -$10K |
|
2587
PUT
AGCO
AGCO
$7.16B
| $1.93M | ﹤0.01% |
32,200
-3,400
| -10% | -$193K |
|
2588
PUT
Labcorp
LH
$26.1B
| $1.93M | ﹤0.01% |
22,698
+10,127
| +81% | +$853K |
|
|
LINE
2589
CALL
DELISTED
LINN ENERGY LLC COM UTS REP LTD LIABILITY CO INTS
LINE
| $1.93M | ﹤0.01% |
77,100
-15,500
| -17% | -$401K |
|
|
CAVM
2590
DELISTED
Cavium, Inc.
CAVM
| $1.93M | ﹤0.01% |
46,984
-25,208
| -35% | -$949K |
|
|
PRXL
2591
DELISTED
Parexel International Corp
PRXL
| $1.93M | ﹤0.01% |
38,496
-5,288
| -12% | -$259K |
|
|
CRZO
2592
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $1.92M | ﹤0.01% |
51,999
-26,402
| -34% | -$878K |
|
2593
Cognex
CGNX
$11B
| $1.92M | ﹤0.01% |
124,000
-12,324
| -9% | -$172K |
|
2594
CALL
Children's Place
PLCE
$58M
| $1.92M | ﹤0.01% |
33,700
+4,700
| +16% | +$258K |
|
2595
Ultrapar
UGP
$6.56B
| $1.92M | ﹤0.01% |
159,762
+58,644
| +58% | +$693K |
|
|
AMTD
2596
PUT
DELISTED
TD Ameritrade Holding Corp
AMTD
| $1.92M | ﹤0.01% |
73,700
+10,000
| +16% | +$266K |
|
2597
CALL
Progressive
PGR
$124B
| $1.91M | ﹤0.01% |
70,900
-186,400
| -72% | -$4.83M |
|
2598
Hanover Insurance
THG
$7.8B
| $1.91M | ﹤0.01% |
34,763
-3,908
| -10% | -$208K |
|
|
CFD
2599
DELISTED
Nuveen Diversified Commodity Fnd
CFD
| $1.91M | ﹤0.01% |
119,480
+5,301
| +5% | +$90K |
|
2600
Patterson-UTI
PTEN
$4.16B
| $1.91M | ﹤0.01% |
90,972
+55
| +0.1% | +$1.13K |
|
Similar funds
Barclays's Q3 2013 Portfolio in Review
As of Q3 2013, Barclays held 8,017 positions worth $83.8B, up 4.2% from $80.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays's Q3 2013 filing shows 302 new, 3,328 increased, 3,470 reduced and 580 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M. The largest sale was SPRINT CORP FON COM, an estimated $724M.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 4.5% a quarter earlier, followed by Healthcare and Technology.
- Barclays's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M.
- Barclays added most to iPath ETNs Linked to the MSCI India Total Return Index in Q3 2013, an estimated $1.36B increase.
- Barclays's biggest Q3 2013 reduction was Pfizer, cutting an estimated $469M.
- Barclays fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $724M.
- Barclays's ten largest holdings make up 26% of its $83.8B portfolio in Q3 2013.
- Barclays opened 302 new positions and closed 580 in Q3 2013.
- Barclays's portfolio value rose 4.2% quarter-over-quarter to $83.8B.
Based on Barclays's 13F filing for Q3 2013, filed 14 Nov 2013.